aluates Reports

$ 0.0

Automative

Global Mammalian Cell Line Development Market Research Report 2026

Published Date: 2026-01-30

Report Code: QYRE-Auto-0Y18827

Global Mammalian Cell Line Development Market Research Report 2024

BUY CHAPTERS

Global Mammalian Cell Line Development Market Research Report 2026

Code: QYRE-Auto-0Y18827

Report

2026-01-30

Pages:157

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Thermo Fisher Scientific

AGC Biologics

Fraunhofer

Cytena

GTP Bioways

KBI Biopharma

Lonza

Abzena

FUJIFILM Diosynth Biotechnologies

Wuxi Biologics

Northway Biotech

Sartorius

EirGenix Inc.

FyoniBio GmbH

Creative Biogene

Rodon Biologics

Tanvex

Menarini Biotech

Mammalian Cell Line Development Market Size

The global Mammalian Cell Line Development market was valued at US$ 278 million in 2025 and is anticipated to reach US$ 520 million by 2032, at a CAGR of 9.5% from 2026 to 2032.

Mammalian Cell Line Development Market

Mammalian cell line development refers to the process of creating and optimizing cell lines derived from mammalian species, such as humans, mice, or monkeys, for use in research, biopharmaceutical production, and other applications. This involves selecting a suitable cell type, establishing a stable cell line, and optimizing growth conditions to ensure high productivity and consistency. Mammalian cell lines are commonly used in the production of recombinant proteins, monoclonal antibodies, and vaccines, as they closely mimic the physiology and function of human cells, making them valuable tools for studying disease mechanisms and developing new therapies. The development of mammalian cell lines is a crucial step in biotechnology and biomedical research, enabling the production of complex biological molecules and advancing our understanding of human health and disease.

The mammalian cell line development industry is undergoing transformative advancements driven by technological innovation, regulatory demands, and emerging therapeutic paradigms. A central trend is the accelerated adoption of CRISPR-Cas9 gene-editing technologies, which have revolutionized cell line optimization by enabling precise genomic modifications to enhance protein expression, metabolic pathways, and host cell resilience. Single-cell sequencing (scRNA-seq) and AI-driven analytics are reshaping cell line characterization and process optimization. By profiling thousands of individual cells, scRNA-seq identifies rare high-producing clones and uncovers heterogeneity in cell populations, while AI algorithms predict clone stability and optimize culture conditions. For example, AI models trained on multi-omics data can reduce clone screening time by 40% by prioritizing clones with favorable genetic and phenotypic profiles.

Continuous manufacturing and single-use technologies are also gaining traction, driven by the need for flexibility and cost efficiency. Single-use bioreactors and integrated downstream processing systems (e.g., chromatography columns) eliminate cleaning validation steps and reduce capital costs, while continuous perfusion cultures maintain high cell densities (>50 million cells/mL) and prolong production cycles, increasing volumetric productivity by 2–3 fold.

Regulatory pressures are pushing for enhanced quality control and traceability. The FDA’s 2023 establishment of the Office of Therapeutic Products (OTP) streamlines reviews for cell and gene therapies, emphasizing real-time monitoring and long-term safety data (e.g., 15-year follow-up for CAR-T patients). Meanwhile, emerging markets like China and India are driving growth, with China investing $58 million in stem cell research and India’s cell line development market projected to grow at 11.6% CAGR through 2030. These regions are leveraging cost-effective manufacturing and government incentives to become global hubs for biosimilars and novel biologics.

Challenges persist, including contamination risks (e.g., mycoplasma affecting 5–30% of cell cultures) and high development costs (e.g., a vial of CHO cells costs ~$4,250). However, advancements in automated imaging systems and CRISPR-based contamination detection tools are mitigating these issues.

This report delivers a comprehensive overview of the global Mammalian Cell Line Development market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Mammalian Cell Line Development. The Mammalian Cell Line Development market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Mammalian Cell Line Development market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Mammalian Cell Line Development manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Mammalian Cell Line Development Market Report

Report Metric	Details
Report Name	Mammalian Cell Line Development Market
Accounted market size in 2025	US$ 278 million
Forecasted market size in 2032	US$ 520 million
CAGR	9.5%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	CHO (Chinese Hamster Ovary) Cells HEK (Human Embryonic Kidney) Cells NS0 (Mouse Myeloma) Cells BHK (Baby Hamster Kidney) Cells Others
Segment by Application	Biopharmaceutical Production Drug Discovery and Development Toxicity Testing Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Thermo Fisher Scientific, AGC Biologics, FyoniBio, KBI Biopharma, Hera Biolabs, Catalent, Bionova, Lonza, Creative Biolabs, Fraunhofer, Cytena, GTP Bioways, Abzena, FUJIFILM Diosynth Biotechnologies, WuXi Biologics, Northway Biotech, Sartorius, EirGenix, Tanvex, Menarini Biotech, Creative Biogene, Rodon Biologics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Mammalian Cell Line Development companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Mammalian Cell Line Development Market growing?

Ans: The Mammalian Cell Line Development Market witnessing a CAGR of 9.5% during the forecast period 2026-2032.

What is the Mammalian Cell Line Development Market size in 2032?

Ans: The Mammalian Cell Line Development Market size in 2032 will be US$ 520 million.

Who are the main players in the Mammalian Cell Line Development Market report?

Ans: The main players in the Mammalian Cell Line Development Market are Thermo Fisher Scientific, AGC Biologics, FyoniBio, KBI Biopharma, Hera Biolabs, Catalent, Bionova, Lonza, Creative Biolabs, Fraunhofer, Cytena, GTP Bioways, Abzena, FUJIFILM Diosynth Biotechnologies, WuXi Biologics, Northway Biotech, Sartorius, EirGenix, Tanvex, Menarini Biotech, Creative Biogene, Rodon Biologics

What are the Application segmentation covered in the Mammalian Cell Line Development Market report?

Ans: The Applications covered in the Mammalian Cell Line Development Market report are Biopharmaceutical Production, Drug Discovery and Development, Toxicity Testing, Others

What are the Type segmentation covered in the Mammalian Cell Line Development Market report?

Ans: The Types covered in the Mammalian Cell Line Development Market report are CHO (Chinese Hamster Ovary) Cells, HEK (Human Embryonic Kidney) Cells, NS0 (Mouse Myeloma) Cells, BHK (Baby Hamster Kidney) Cells, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Mammalian Cell Line Development Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 CHO (Chinese Hamster Ovary) Cells

1.2.3 HEK (Human Embryonic Kidney) Cells

1.2.4 NS0 (Mouse Myeloma) Cells

1.2.5 BHK (Baby Hamster Kidney) Cells

1.2.6 Others

1.3 Market by Application

1.3.1 Global Mammalian Cell Line Development Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Biopharmaceutical Production

1.3.3 Drug Discovery and Development

1.3.4 Toxicity Testing

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Mammalian Cell Line Development Market Perspective (2021–2032)

2.2 Global Mammalian Cell Line Development Growth Trends by Region

2.2.1 Global Mammalian Cell Line Development Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Mammalian Cell Line Development Historic Market Size by Region (2021–2026)

2.2.3 Mammalian Cell Line Development Forecasted Market Size by Region (2027–2032)

2.3 Mammalian Cell Line Development Market Dynamics

2.3.1 Mammalian Cell Line Development Industry Trends

2.3.2 Mammalian Cell Line Development Market Drivers

2.3.3 Mammalian Cell Line Development Market Challenges

2.3.4 Mammalian Cell Line Development Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Mammalian Cell Line Development Players by Revenue

3.1.1 Global Top Mammalian Cell Line Development Players by Revenue (2021–2026)

3.1.2 Global Mammalian Cell Line Development Revenue Market Share by Players (2021–2026)

3.2 Global Top Mammalian Cell Line Development Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Mammalian Cell Line Development Revenue

3.4 Global Mammalian Cell Line Development Market Concentration Ratio

3.4.1 Global Mammalian Cell Line Development Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Mammalian Cell Line Development Revenue in 2025

3.5 Global Key Players of Mammalian Cell Line Development Head Offices and Areas Served

3.6 Global Key Players of Mammalian Cell Line Development, Products and Applications

3.7 Global Key Players of Mammalian Cell Line Development, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Mammalian Cell Line Development Breakdown Data by Type

4.1 Global Mammalian Cell Line Development Historic Market Size by Type (2021–2026)

4.2 Global Mammalian Cell Line Development Forecasted Market Size by Type (2027–2032)

5 Mammalian Cell Line Development Breakdown Data by Application

5.1 Global Mammalian Cell Line Development Historic Market Size by Application (2021–2026)

5.2 Global Mammalian Cell Line Development Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Mammalian Cell Line Development Market Size (2021–2032)

6.2 North America Mammalian Cell Line Development Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Mammalian Cell Line Development Market Size by Country (2021–2026)

6.4 North America Mammalian Cell Line Development Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Mammalian Cell Line Development Market Size (2021–2032)

7.2 Europe Mammalian Cell Line Development Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Mammalian Cell Line Development Market Size by Country (2021–2026)

7.4 Europe Mammalian Cell Line Development Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Mammalian Cell Line Development Market Size (2021–2032)

8.2 Asia-Pacific Mammalian Cell Line Development Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Mammalian Cell Line Development Market Size by Region (2021–2026)

8.4 Asia-Pacific Mammalian Cell Line Development Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Mammalian Cell Line Development Market Size (2021–2032)

9.2 Latin America Mammalian Cell Line Development Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Mammalian Cell Line Development Market Size by Country (2021–2026)

9.4 Latin America Mammalian Cell Line Development Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Mammalian Cell Line Development Market Size (2021–2032)

10.2 Middle East & Africa Mammalian Cell Line Development Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Mammalian Cell Line Development Market Size by Country (2021–2026)

10.4 Middle East & Africa Mammalian Cell Line Development Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Thermo Fisher Scientific

11.1.1 Thermo Fisher Scientific Company Details

11.1.2 Thermo Fisher Scientific Business Overview

11.1.3 Thermo Fisher Scientific Mammalian Cell Line Development Introduction

11.1.4 Thermo Fisher Scientific Revenue in Mammalian Cell Line Development Business (2021–2026)

11.1.5 Thermo Fisher Scientific Recent Development

11.2 AGC Biologics

11.2.1 AGC Biologics Company Details

11.2.2 AGC Biologics Business Overview

11.2.3 AGC Biologics Mammalian Cell Line Development Introduction

11.2.4 AGC Biologics Revenue in Mammalian Cell Line Development Business (2021–2026)

11.2.5 AGC Biologics Recent Development

11.3 FyoniBio

11.3.1 FyoniBio Company Details

11.3.2 FyoniBio Business Overview

11.3.3 FyoniBio Mammalian Cell Line Development Introduction

11.3.4 FyoniBio Revenue in Mammalian Cell Line Development Business (2021–2026)

11.3.5 FyoniBio Recent Development

11.4 KBI Biopharma

11.4.1 KBI Biopharma Company Details

11.4.2 KBI Biopharma Business Overview

11.4.3 KBI Biopharma Mammalian Cell Line Development Introduction

11.4.4 KBI Biopharma Revenue in Mammalian Cell Line Development Business (2021–2026)

11.4.5 KBI Biopharma Recent Development

11.5 Hera Biolabs

11.5.1 Hera Biolabs Company Details

11.5.2 Hera Biolabs Business Overview

11.5.3 Hera Biolabs Mammalian Cell Line Development Introduction

11.5.4 Hera Biolabs Revenue in Mammalian Cell Line Development Business (2021–2026)

11.5.5 Hera Biolabs Recent Development

11.6 Catalent

11.6.1 Catalent Company Details

11.6.2 Catalent Business Overview

11.6.3 Catalent Mammalian Cell Line Development Introduction

11.6.4 Catalent Revenue in Mammalian Cell Line Development Business (2021–2026)

11.6.5 Catalent Recent Development

11.7 Bionova

11.7.1 Bionova Company Details

11.7.2 Bionova Business Overview

11.7.3 Bionova Mammalian Cell Line Development Introduction

11.7.4 Bionova Revenue in Mammalian Cell Line Development Business (2021–2026)

11.7.5 Bionova Recent Development

11.8 Lonza

11.8.1 Lonza Company Details

11.8.2 Lonza Business Overview

11.8.3 Lonza Mammalian Cell Line Development Introduction

11.8.4 Lonza Revenue in Mammalian Cell Line Development Business (2021–2026)

11.8.5 Lonza Recent Development

11.9 Creative Biolabs

11.9.1 Creative Biolabs Company Details

11.9.2 Creative Biolabs Business Overview

11.9.3 Creative Biolabs Mammalian Cell Line Development Introduction

11.9.4 Creative Biolabs Revenue in Mammalian Cell Line Development Business (2021–2026)

11.9.5 Creative Biolabs Recent Development

11.10 Fraunhofer

11.10.1 Fraunhofer Company Details

11.10.2 Fraunhofer Business Overview

11.10.3 Fraunhofer Mammalian Cell Line Development Introduction

11.10.4 Fraunhofer Revenue in Mammalian Cell Line Development Business (2021–2026)

11.10.5 Fraunhofer Recent Development

11.11 Cytena

11.11.1 Cytena Company Details

11.11.2 Cytena Business Overview

11.11.3 Cytena Mammalian Cell Line Development Introduction

11.11.4 Cytena Revenue in Mammalian Cell Line Development Business (2021–2026)

11.11.5 Cytena Recent Development

11.12 GTP Bioways

11.12.1 GTP Bioways Company Details

11.12.2 GTP Bioways Business Overview

11.12.3 GTP Bioways Mammalian Cell Line Development Introduction

11.12.4 GTP Bioways Revenue in Mammalian Cell Line Development Business (2021–2026)

11.12.5 GTP Bioways Recent Development

11.13 Abzena

11.13.1 Abzena Company Details

11.13.2 Abzena Business Overview

11.13.3 Abzena Mammalian Cell Line Development Introduction

11.13.4 Abzena Revenue in Mammalian Cell Line Development Business (2021–2026)

11.13.5 Abzena Recent Development

11.14 FUJIFILM Diosynth Biotechnologies

11.14.1 FUJIFILM Diosynth Biotechnologies Company Details

11.14.2 FUJIFILM Diosynth Biotechnologies Business Overview

11.14.3 FUJIFILM Diosynth Biotechnologies Mammalian Cell Line Development Introduction

11.14.4 FUJIFILM Diosynth Biotechnologies Revenue in Mammalian Cell Line Development Business (2021–2026)

11.14.5 FUJIFILM Diosynth Biotechnologies Recent Development

11.15 WuXi Biologics

11.15.1 WuXi Biologics Company Details

11.15.2 WuXi Biologics Business Overview

11.15.3 WuXi Biologics Mammalian Cell Line Development Introduction

11.15.4 WuXi Biologics Revenue in Mammalian Cell Line Development Business (2021–2026)

11.15.5 WuXi Biologics Recent Development

11.16 Northway Biotech

11.16.1 Northway Biotech Company Details

11.16.2 Northway Biotech Business Overview

11.16.3 Northway Biotech Mammalian Cell Line Development Introduction

11.16.4 Northway Biotech Revenue in Mammalian Cell Line Development Business (2021–2026)

11.16.5 Northway Biotech Recent Development

11.17 Sartorius

11.17.1 Sartorius Company Details

11.17.2 Sartorius Business Overview

11.17.3 Sartorius Mammalian Cell Line Development Introduction

11.17.4 Sartorius Revenue in Mammalian Cell Line Development Business (2021–2026)

11.17.5 Sartorius Recent Development

11.18 EirGenix

11.18.1 EirGenix Company Details

11.18.2 EirGenix Business Overview

11.18.3 EirGenix Mammalian Cell Line Development Introduction

11.18.4 EirGenix Revenue in Mammalian Cell Line Development Business (2021–2026)

11.18.5 EirGenix Recent Development

11.19 Tanvex

11.19.1 Tanvex Company Details

11.19.2 Tanvex Business Overview

11.19.3 Tanvex Mammalian Cell Line Development Introduction

11.19.4 Tanvex Revenue in Mammalian Cell Line Development Business (2021–2026)

11.19.5 Tanvex Recent Development

11.20 Menarini Biotech

11.20.1 Menarini Biotech Company Details

11.20.2 Menarini Biotech Business Overview

11.20.3 Menarini Biotech Mammalian Cell Line Development Introduction

11.20.4 Menarini Biotech Revenue in Mammalian Cell Line Development Business (2021–2026)

11.20.5 Menarini Biotech Recent Development

11.21 Creative Biogene

11.21.1 Creative Biogene Company Details

11.21.2 Creative Biogene Business Overview

11.21.3 Creative Biogene Mammalian Cell Line Development Introduction

11.21.4 Creative Biogene Revenue in Mammalian Cell Line Development Business (2021–2026)

11.21.5 Creative Biogene Recent Development

11.22 Rodon Biologics

11.22.1 Rodon Biologics Company Details

11.22.2 Rodon Biologics Business Overview

11.22.3 Rodon Biologics Mammalian Cell Line Development Introduction

11.22.4 Rodon Biologics Revenue in Mammalian Cell Line Development Business (2021–2026)

11.22.5 Rodon Biologics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Thermo Fisher Scientific

AGC Biologics

Fraunhofer

Cytena

GTP Bioways

KBI Biopharma

Lonza

Abzena

FUJIFILM Diosynth Biotechnologies

Wuxi Biologics

Northway Biotech

Sartorius

EirGenix Inc.

FyoniBio GmbH

Creative Biogene

Rodon Biologics

Tanvex

Menarini Biotech

List of Tables

Table 1. Global Mammalian Cell Line Development Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of CHO (Chinese Hamster Ovary) Cells

Table 3. Key Players of HEK (Human Embryonic Kidney) Cells

Table 4. Key Players of NS0 (Mouse Myeloma) Cells

Table 5. Key Players of BHK (Baby Hamster Kidney) Cells

Table 6. Key Players of Others

Table 7. Global Mammalian Cell Line Development Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 8. Global Mammalian Cell Line Development Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 9. Global Mammalian Cell Line Development Market Size by Region (US$ Million), 2021–2026

Table 10. Global Mammalian Cell Line Development Market Share by Region (2021–2026)

Table 11. Global Mammalian Cell Line Development Forecasted Market Size by Region (US$ Million), 2027–2032

Table 12. Global Mammalian Cell Line Development Market Share by Region (2027–2032)

Table 13. Mammalian Cell Line Development Market Trends

Table 14. Mammalian Cell Line Development Market Drivers

Table 15. Mammalian Cell Line Development Market Challenges

Table 16. Mammalian Cell Line Development Market Restraints

Table 17. Global Mammalian Cell Line Development Revenue by Players (US$ Million), 2021–2026

Table 18. Global Mammalian Cell Line Development Market Share by Players (2021–2026)

Table 19. Global Top Mammalian Cell Line Development Players by Tier (Tier 1, Tier 2, and Tier 3), based on Mammalian Cell Line Development Revenue, 2025

Table 20. Ranking of Global Top Mammalian Cell Line Development Companies by Revenue (US$ Million) in 2025

Table 21. Global 5 Largest Players Market Share by Mammalian Cell Line Development Revenue (CR5 and HHI), 2021–2026

Table 22. Global Key Players of Mammalian Cell Line Development, Headquarters and Area Served

Table 23. Global Key Players of Mammalian Cell Line Development, Products and Applications

Table 24. Global Key Players of Mammalian Cell Line Development, Date of General Availability (GA)

Table 25. Mergers and Acquisitions, Expansion Plans

Table 26. Global Mammalian Cell Line Development Market Size by Type (US$ Million), 2021–2026

Table 27. Global Mammalian Cell Line Development Revenue Market Share by Type (2021–2026)

Table 28. Global Mammalian Cell Line Development Forecasted Market Size by Type (US$ Million), 2027–2032

Table 29. Global Mammalian Cell Line Development Revenue Market Share by Type (2027–2032)

Table 30. Global Mammalian Cell Line Development Market Size by Application (US$ Million), 2021–2026

Table 31. Global Mammalian Cell Line Development Revenue Market Share by Application (2021–2026)

Table 32. Global Mammalian Cell Line Development Forecasted Market Size by Application (US$ Million), 2027–2032

Table 33. Global Mammalian Cell Line Development Revenue Market Share by Application (2027–2032)

Table 34. North America Mammalian Cell Line Development Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 35. North America Mammalian Cell Line Development Market Size by Country (US$ Million), 2021–2026

Table 36. North America Mammalian Cell Line Development Market Size by Country (US$ Million), 2027–2032

Table 37. Europe Mammalian Cell Line Development Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 38. Europe Mammalian Cell Line Development Market Size by Country (US$ Million), 2021–2026

Table 39. Europe Mammalian Cell Line Development Market Size by Country (US$ Million), 2027–2032

Table 40. Asia-Pacific Mammalian Cell Line Development Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 41. Asia-Pacific Mammalian Cell Line Development Market Size by Region (US$ Million), 2021–2026

Table 42. Asia-Pacific Mammalian Cell Line Development Market Size by Region (US$ Million), 2027–2032

Table 43. Latin America Mammalian Cell Line Development Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 44. Latin America Mammalian Cell Line Development Market Size by Country (US$ Million), 2021–2026

Table 45. Latin America Mammalian Cell Line Development Market Size by Country (US$ Million), 2027–2032

Table 46. Middle East & Africa Mammalian Cell Line Development Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 47. Middle East & Africa Mammalian Cell Line Development Market Size by Country (US$ Million), 2021–2026

Table 48. Middle East & Africa Mammalian Cell Line Development Market Size by Country (US$ Million), 2027–2032

Table 49. Thermo Fisher Scientific Company Details

Table 50. Thermo Fisher Scientific Business Overview

Table 51. Thermo Fisher Scientific Mammalian Cell Line Development Product

Table 52. Thermo Fisher Scientific Revenue in Mammalian Cell Line Development Business (US$ Million), 2021–2026

Table 53. Thermo Fisher Scientific Recent Development

Table 54. AGC Biologics Company Details

Table 55. AGC Biologics Business Overview

Table 56. AGC Biologics Mammalian Cell Line Development Product

Table 57. AGC Biologics Revenue in Mammalian Cell Line Development Business (US$ Million), 2021–2026

Table 58. AGC Biologics Recent Development

Table 59. FyoniBio Company Details

Table 60. FyoniBio Business Overview

Table 61. FyoniBio Mammalian Cell Line Development Product

Table 62. FyoniBio Revenue in Mammalian Cell Line Development Business (US$ Million), 2021–2026

Table 63. FyoniBio Recent Development

Table 64. KBI Biopharma Company Details

Table 65. KBI Biopharma Business Overview

Table 66. KBI Biopharma Mammalian Cell Line Development Product

Table 67. KBI Biopharma Revenue in Mammalian Cell Line Development Business (US$ Million), 2021–2026

Table 68. KBI Biopharma Recent Development

Table 69. Hera Biolabs Company Details

Table 70. Hera Biolabs Business Overview

Table 71. Hera Biolabs Mammalian Cell Line Development Product

Table 72. Hera Biolabs Revenue in Mammalian Cell Line Development Business (US$ Million), 2021–2026

Table 73. Hera Biolabs Recent Development

Table 74. Catalent Company Details

Table 75. Catalent Business Overview

Table 76. Catalent Mammalian Cell Line Development Product

Table 77. Catalent Revenue in Mammalian Cell Line Development Business (US$ Million), 2021–2026

Table 78. Catalent Recent Development

Table 79. Bionova Company Details

Table 80. Bionova Business Overview

Table 81. Bionova Mammalian Cell Line Development Product

Table 82. Bionova Revenue in Mammalian Cell Line Development Business (US$ Million), 2021–2026

Table 83. Bionova Recent Development

Table 84. Lonza Company Details

Table 85. Lonza Business Overview

Table 86. Lonza Mammalian Cell Line Development Product

Table 87. Lonza Revenue in Mammalian Cell Line Development Business (US$ Million), 2021–2026

Table 88. Lonza Recent Development

Table 89. Creative Biolabs Company Details

Table 90. Creative Biolabs Business Overview

Table 91. Creative Biolabs Mammalian Cell Line Development Product

Table 92. Creative Biolabs Revenue in Mammalian Cell Line Development Business (US$ Million), 2021–2026

Table 93. Creative Biolabs Recent Development

Table 94. Fraunhofer Company Details

Table 95. Fraunhofer Business Overview

Table 96. Fraunhofer Mammalian Cell Line Development Product

Table 97. Fraunhofer Revenue in Mammalian Cell Line Development Business (US$ Million), 2021–2026

Table 98. Fraunhofer Recent Development

Table 99. Cytena Company Details

Table 100. Cytena Business Overview

Table 101. Cytena Mammalian Cell Line Development Product

Table 102. Cytena Revenue in Mammalian Cell Line Development Business (US$ Million), 2021–2026

Table 103. Cytena Recent Development

Table 104. GTP Bioways Company Details

Table 105. GTP Bioways Business Overview

Table 106. GTP Bioways Mammalian Cell Line Development Product

Table 107. GTP Bioways Revenue in Mammalian Cell Line Development Business (US$ Million), 2021–2026

Table 108. GTP Bioways Recent Development

Table 109. Abzena Company Details

Table 110. Abzena Business Overview

Table 111. Abzena Mammalian Cell Line Development Product

Table 112. Abzena Revenue in Mammalian Cell Line Development Business (US$ Million), 2021–2026

Table 113. Abzena Recent Development

Table 114. FUJIFILM Diosynth Biotechnologies Company Details

Table 115. FUJIFILM Diosynth Biotechnologies Business Overview

Table 116. FUJIFILM Diosynth Biotechnologies Mammalian Cell Line Development Product

Table 117. FUJIFILM Diosynth Biotechnologies Revenue in Mammalian Cell Line Development Business (US$ Million), 2021–2026

Table 118. FUJIFILM Diosynth Biotechnologies Recent Development

Table 119. WuXi Biologics Company Details

Table 120. WuXi Biologics Business Overview

Table 121. WuXi Biologics Mammalian Cell Line Development Product

Table 122. WuXi Biologics Revenue in Mammalian Cell Line Development Business (US$ Million), 2021–2026

Table 123. WuXi Biologics Recent Development

Table 124. Northway Biotech Company Details

Table 125. Northway Biotech Business Overview

Table 126. Northway Biotech Mammalian Cell Line Development Product

Table 127. Northway Biotech Revenue in Mammalian Cell Line Development Business (US$ Million), 2021–2026

Table 128. Northway Biotech Recent Development

Table 129. Sartorius Company Details

Table 130. Sartorius Business Overview

Table 131. Sartorius Mammalian Cell Line Development Product

Table 132. Sartorius Revenue in Mammalian Cell Line Development Business (US$ Million), 2021–2026

Table 133. Sartorius Recent Development

Table 134. EirGenix Company Details

Table 135. EirGenix Business Overview

Table 136. EirGenix Mammalian Cell Line Development Product

Table 137. EirGenix Revenue in Mammalian Cell Line Development Business (US$ Million), 2021–2026

Table 138. EirGenix Recent Development

Table 139. Tanvex Company Details

Table 140. Tanvex Business Overview

Table 141. Tanvex Mammalian Cell Line Development Product

Table 142. Tanvex Revenue in Mammalian Cell Line Development Business (US$ Million), 2021–2026

Table 143. Tanvex Recent Development

Table 144. Menarini Biotech Company Details

Table 145. Menarini Biotech Business Overview

Table 146. Menarini Biotech Mammalian Cell Line Development Product

Table 147. Menarini Biotech Revenue in Mammalian Cell Line Development Business (US$ Million), 2021–2026

Table 148. Menarini Biotech Recent Development

Table 149. Creative Biogene Company Details

Table 150. Creative Biogene Business Overview

Table 151. Creative Biogene Mammalian Cell Line Development Product

Table 152. Creative Biogene Revenue in Mammalian Cell Line Development Business (US$ Million), 2021–2026

Table 153. Creative Biogene Recent Development

Table 154. Rodon Biologics Company Details

Table 155. Rodon Biologics Business Overview

Table 156. Rodon Biologics Mammalian Cell Line Development Product

Table 157. Rodon Biologics Revenue in Mammalian Cell Line Development Business (US$ Million), 2021–2026

Table 158. Rodon Biologics Recent Development

Table 159. Research Programs/Design for This Report

Table 160. Key Data Information from Secondary Sources

Table 161. Key Data Information from Primary Sources

Table 162. Authors List of This Report

List of Figures

Figure 1. Mammalian Cell Line Development Picture

Figure 2. Global Mammalian Cell Line Development Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Mammalian Cell Line Development Market Share by Type: 2025 vs 2032

Figure 4. CHO (Chinese Hamster Ovary) Cells Features

Figure 5. HEK (Human Embryonic Kidney) Cells Features

Figure 6. NS0 (Mouse Myeloma) Cells Features

Figure 7. BHK (Baby Hamster Kidney) Cells Features

Figure 8. Others Features

Figure 9. Global Mammalian Cell Line Development Market Size by Application (US$ Million), 2021–2032

Figure 10. Global Mammalian Cell Line Development Market Share by Application: 2025 vs 2032

Figure 11. Biopharmaceutical Production Case Studies

Figure 12. Drug Discovery and Development Case Studies

Figure 13. Toxicity Testing Case Studies

Figure 14. Others Case Studies

Figure 15. Mammalian Cell Line Development Report Years Considered

Figure 16. Global Mammalian Cell Line Development Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 17. Global Mammalian Cell Line Development Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 18. Global Mammalian Cell Line Development Market Share by Region: 2025 vs 2032

Figure 19. Global Mammalian Cell Line Development Market Share by Players in 2025

Figure 20. Global Mammalian Cell Line Development Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 21. The Top 10 and 5 Players Market Share by Mammalian Cell Line Development Revenue in 2025

Figure 22. North America Mammalian Cell Line Development Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. North America Mammalian Cell Line Development Market Share by Country (2021–2032)

Figure 24. United States Mammalian Cell Line Development Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. Canada Mammalian Cell Line Development Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. Europe Mammalian Cell Line Development Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. Europe Mammalian Cell Line Development Market Share by Country (2021–2032)

Figure 28. Germany Mammalian Cell Line Development Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. France Mammalian Cell Line Development Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. U.K. Mammalian Cell Line Development Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Italy Mammalian Cell Line Development Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Russia Mammalian Cell Line Development Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Ireland Mammalian Cell Line Development Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Asia-Pacific Mammalian Cell Line Development Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Asia-Pacific Mammalian Cell Line Development Market Share by Region (2021–2032)

Figure 36. China Mammalian Cell Line Development Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Japan Mammalian Cell Line Development Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. South Korea Mammalian Cell Line Development Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Southeast Asia Mammalian Cell Line Development Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. India Mammalian Cell Line Development Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Australia & New Zealand Mammalian Cell Line Development Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Latin America Mammalian Cell Line Development Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Latin America Mammalian Cell Line Development Market Share by Country (2021–2032)

Figure 44. Mexico Mammalian Cell Line Development Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Brazil Mammalian Cell Line Development Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Middle East & Africa Mammalian Cell Line Development Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Middle East & Africa Mammalian Cell Line Development Market Share by Country (2021–2032)

Figure 48. Israel Mammalian Cell Line Development Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. Saudi Arabia Mammalian Cell Line Development Market Size YoY Growth (US$ Million), 2021–2032

Figure 50. UAE Mammalian Cell Line Development Market Size YoY Growth (US$ Million), 2021–2032

Figure 51. Thermo Fisher Scientific Revenue Growth Rate in Mammalian Cell Line Development Business (2021–2026)

Figure 52. AGC Biologics Revenue Growth Rate in Mammalian Cell Line Development Business (2021–2026)

Figure 53. FyoniBio Revenue Growth Rate in Mammalian Cell Line Development Business (2021–2026)

Figure 54. KBI Biopharma Revenue Growth Rate in Mammalian Cell Line Development Business (2021–2026)

Figure 55. Hera Biolabs Revenue Growth Rate in Mammalian Cell Line Development Business (2021–2026)

Figure 56. Catalent Revenue Growth Rate in Mammalian Cell Line Development Business (2021–2026)

Figure 57. Bionova Revenue Growth Rate in Mammalian Cell Line Development Business (2021–2026)

Figure 58. Lonza Revenue Growth Rate in Mammalian Cell Line Development Business (2021–2026)

Figure 59. Creative Biolabs Revenue Growth Rate in Mammalian Cell Line Development Business (2021–2026)

Figure 60. Fraunhofer Revenue Growth Rate in Mammalian Cell Line Development Business (2021–2026)

Figure 61. Cytena Revenue Growth Rate in Mammalian Cell Line Development Business (2021–2026)

Figure 62. GTP Bioways Revenue Growth Rate in Mammalian Cell Line Development Business (2021–2026)

Figure 63. Abzena Revenue Growth Rate in Mammalian Cell Line Development Business (2021–2026)

Figure 64. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Mammalian Cell Line Development Business (2021–2026)

Figure 65. WuXi Biologics Revenue Growth Rate in Mammalian Cell Line Development Business (2021–2026)

Figure 66. Northway Biotech Revenue Growth Rate in Mammalian Cell Line Development Business (2021–2026)

Figure 67. Sartorius Revenue Growth Rate in Mammalian Cell Line Development Business (2021–2026)

Figure 68. EirGenix Revenue Growth Rate in Mammalian Cell Line Development Business (2021–2026)

Figure 69. Tanvex Revenue Growth Rate in Mammalian Cell Line Development Business (2021–2026)

Figure 70. Menarini Biotech Revenue Growth Rate in Mammalian Cell Line Development Business (2021–2026)

Figure 71. Creative Biogene Revenue Growth Rate in Mammalian Cell Line Development Business (2021–2026)

Figure 72. Rodon Biologics Revenue Growth Rate in Mammalian Cell Line Development Business (2021–2026)

Figure 73. Bottom-up and Top-down Approaches for This Report

Figure 74. Data Triangulation

Figure 75. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Mammalian Cell Banking Market Research Report 2025

Cell Line Development for Biologics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cell Line Generation Market Research Report 2025

Global Cell Line Construction Service Market Research Report 2024

Global Stable Cell Line Development Market Insights Forecast to 2030

Mammalian Cell Culture Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Mammalian Cell Expression System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Mammalian Protein Expression System Market Research Report 2024

Global CRISPR Cell Line Development Market Research Report 2024

Global Chinese Hamster Ovary Cell Line Market Research Report 2024

Global CHO Cell Line Construction Service Market Research Report 2024

Global CHO Cell Line Development Service Market Research Report 2024

Global Mammalian Expression Systems Market Research Report 2025

Global Cell Culture Service Market Research Report 2025

Global Cell Line Customization Service Market Research Report 2024

Research Use Human Cells Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cell Line Development Serum Market Research Report 2024

Global Mouse Cell Line Authentication Service Market Research Report 2025

Global Mammalian Cell Display Service Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions